| tip : |
ziar |
| Internet legătură într- : |
https://doi.org/10.1155/2022/1931118 |
|
| Echipe de cercetare : |
Paris - Clinical Pharmacy Department, University Hospital Necker-Enfants Malades |
| Autor : |
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J. |
| titlu : |
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. |
| Référence : |
The Scientific World Journal 2022 |
|
| Nivelul dovezii : |
|
| stabilitatea fizică : |
|
| Stabilitate chimică : |
|
| alte metode : |
|
| Comentarii : |
|
Listele
 Ruxolitinib
|
 |
 |
 |
 |
100 mg
Jakavi® (Novartis) |
|
2-8°C |
 |
| 60 |
 |
|
|
|
|
|
100 mg
Jakavi® (Novartis) |
|
22-25°C |
|
| 60 |
|
|
|
|
|
